Experts criticise EMA decision to restrict use of durvalumab

• Univadis Medical News
• 17 January 2019

Several countries have approved durvalumab as consolidation therapy for unselected unresectable stage III non-small cell lung cancer.

Ten threats to global health in 2019

• Univadis Medical News
• 17 January 2019

The World Health Organization has published a list of 10 issues that will demand the attention of the organisation and health partners this year.

Ulcerative colitis: faecal microbiota transplantation with anaerobically prepared stool

• Univadis Medical News
• 17 January 2019

Findings from a new randomised controlled trial.

Young-onset diabetes linked to higher risk of all-cause hospitalisation

• Univadis Medical News
• 17 January 2019

New research has also identified an unexpectedly large burden of mental illness in patients diagnosed with diabetes before the age of 40 years.

Prescribed opioids raise risk of pneumonia in patients with and without HIV

• Medical News
• 16 January 2019

A nested study published in JAMA Internal Medicine confirms the immunosuppressive effects of some opioids and the increased risk of community-acquired pneumonia in people living with HIV using opioids at higher doses

SABCS 2018 — Lifestyle intervention improves weight loss after chemotherapy

• Univadis
• 10 December 2018

Program completers had better DFS in unplanned subgroup analyses.

SABCS 2018 — Mastectomy, radiation associated with some reduced QoL measures

• Univadis
• 10 December 2018

Financial discomfort also linked to reduced QoL measures.

SABCS 2018 — Oxybutynin reduces hot-flash frequency and interference with QoL

• Univadis
• 10 December 2018

Long-term toxicity data, including potential cognitive decline, lacking.